“Authors’ Reply – Comments: Serum Levels of Infliximab in Brazilian Patients With Crohn’s Disease: What Are the Reasons for Differences from Previous Studies?”. Clinics 74 (October 9, 2019): e1517. Accessed April 28, 2024. https://revistas.usp.br/clinics/article/view/163040.